A successful case of dupilumab treatment for severe uremic pruritus

Jonathan I. Silverberg*, Joaquin Brieva

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

24 Scopus citations
Original languageEnglish (US)
Pages (from-to)339-341
Number of pages3
JournalJAAD Case Reports
Volume5
Issue number4
DOIs
StatePublished - Apr 2019

Funding

Conflicts of interest: Dr Silverberg served as a consultant and/or advisory board member for Abbvie, Asana, Dermavant, Dermira, Eli Lilly, Galderma, GlaxoSmithKline, Glenmark, Kiniksa, Leo, Menlo, Pfizer, Regeneron-Sanofi. He also received honoraria from Realm, was a speaker for Regeneron-Sanofi, and received research grants from GlaxoSmithKline. Dr Silverberg is supported by the Dermatology Foundation. Dr Brieva has no conflicts to disclose. Funding sources: None. Conflicts of interest: Dr Silverberg served as a consultant and/or advisory board member for Abbvie, Asana, Dermavant, Dermira, Eli Lilly, Galderma, GlaxoSmithKline, Glenmark, Kiniksa, Leo, Menlo, Pfizer, Regeneron-Sanofi. He also received honoraria from Realm, was a speaker for Regeneron-Sanofi, and received research grants from GlaxoSmithKline. Dr Silverberg is supported by the Dermatology Foundation. Dr Brieva has no conflicts to disclose.

Keywords

  • itch
  • scratch
  • treatment
  • uremic pruritus

ASJC Scopus subject areas

  • Dermatology

Cite this